Abstract

Annotation. Initiated in 2017 by the Government of Ukraine, the “Affordable Medicines” program has undoubtedly become a significant support for the population of Ukraine, however, access to free treatment has often been the reason for taking too high doses of drugs, overdue drugs, etc. This fact was the impetus for us to conduct a study that would help solve the problems that arose during the implementation of the Government program “Affordable Medicines”. A combined (retrospective, prospective) study was conducted in which 150 patients of retirement age took part. Patients were divided into 2 groups. The case group included 100 patients with essential arterial hypertension and gastroduodenitis. The control group consisted of 50 patients with essential arterial hypertension without gastroduodenitis. During the work on the study, attention was focused on the peculiarities of gastroduodenitis in patients taking drugs for the treatment of cardiovascular diseases using the program "Affordable Medicines". Information on the costs of treatment and prevention of essential arterial hypertension and gastroduodenitis is also collected. During the work, the following research methods were used: system approach and system analysis, statistical, epidemiological, sociological, method of statistical modeling according to MCMC algorithms, expert assessments, survival curves. As a result of the study, a gastroduodenitis prevention program was proposed for patients of retirement age with essential arterial hypertension who receive treatment under the Affordable Medicines program. A balance model for assessing the medical and economic efficiency of the proposed prevention program has been developed. The assessment of the medical and economic efficiency of the proposed prevention program according to the developed balance model of evaluation was carried out.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call